BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30944007)

  • 1. Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
    Baravelli CM; Sandberg S; Aarsand AK; Tollånes MC
    Orphanet J Rare Dis; 2019 Apr; 14(1):77. PubMed ID: 30944007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality in patients with porphyria cutanea tarda-A nationwide cohort study.
    Christiansen AL; Brock A; Bygum A; Rasmussen LM; Jepsen P
    J Am Acad Dermatol; 2020 Sep; 83(3):817-823. PubMed ID: 31374307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study.
    Baravelli CM; Aarsand AK; Sandberg S; Tollånes MC
    Orphanet J Rare Dis; 2022 Feb; 17(1):72. PubMed ID: 35193623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.
    Gisbert JP; García-Buey L; Alonso A; Rubio S; Hernández A; Pajares JM; García-Díez A; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):689-92. PubMed ID: 15201583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda: Recent update.
    Singal AK
    Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden.
    Linet MS; Gridley G; Nyrén O; Mellemkjaer L; Olsen JH; Keehn S; Adami HO; Fraumeni JF
    Am J Epidemiol; 1999 Jun; 149(11):1010-5. PubMed ID: 10355376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
    Mogl MT; Pascher A; Presser SJ; Schwabe M; Neuhaus P; Nuessler NC
    World J Gastroenterol; 2007 Apr; 13(13):1998-2001. PubMed ID: 17461505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].
    Moreno FJ; Santoyo J; Bondía JA; Suárez MA; Jiménez M; Fernández JL; Conde M; Marín R; Ribeiro M; Peláez JM; de la Fuente A
    Rev Esp Enferm Dig; 1998 Jan; 90(1):48-50. PubMed ID: 9558946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyria cutanea tarda, hemosiderosis and hepatocellular carcinoma: report of one case].
    Whittle C; Hepp J; Armas R; Schultz M
    Rev Med Chil; 2010 May; 138(5):581-5. PubMed ID: 20668813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of cirrhosis and hepatocellular carcinoma with porphyria cutanea tarda].
    Ishibashi H; Matsunaga T; Dohmen K
    Nihon Rinsho; 1995 Jun; 53(6):1474-8. PubMed ID: 7616664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.
    Huang TS; Lin CL; Lu MJ; Yeh CT; Liang KH; Sun CC; Shyu YC; Chien RN
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1355-1362. PubMed ID: 27930829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda and hepatitis C virus infection.
    Tsukazaki N; Watanabe M; Irifune H
    Br J Dermatol; 1998 Jun; 138(6):1015-7. PubMed ID: 9747364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease.
    Fracanzani AL; Taioli E; Sampietro M; Fatta E; Bertelli C; Fiorelli G; Fargion S
    J Hepatol; 2001 Oct; 35(4):498-503. PubMed ID: 11682034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of porphyria cutanea tarda.
    Sarkany RP
    Clin Exp Dermatol; 2001 May; 26(3):225-32. PubMed ID: 11422163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature.
    Cassiman D; Vannoote J; Roelandts R; Libbrecht L; Roskams T; Van den Oord J; Fevery J; Garmyn M; Nevens F
    Acta Gastroenterol Belg; 2008; 71(2):237-42. PubMed ID: 18720935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Porphyria cutanea tarda, hepatocarcinoma and hepatitis C virus infection].
    Rodríguez Cuartero A; González Martínez F; Ceballos Torres A
    An Med Interna; 1995 Oct; 12(10):517-8. PubMed ID: 8519952
    [No Abstract]   [Full Text] [Related]  

  • 17. Is porphyria cutanea tarda a risk factor in the development of hepatocellular carcinoma? A case report and review of the literature.
    Packe GE; Clarke CW
    Oncology; 1985; 42(1):44-7. PubMed ID: 2982117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of porphyria cutanea tarda and hepatitis C virus].
    Martín-Vivaldi Martínez R; Espinosa Aguilar MD; Sánchez Sanchéz-Vizcaíno J; Quintero Fuentes D; Nogueras López F; López de Hierro Ruiz M
    Rev Esp Enferm Dig; 1996 Mar; 88(3):213-6. PubMed ID: 8645516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum iron and copper and their relations to hepatocellular carcinoma in porphyria cutanea tarda and hemochromatosis patients--case report.
    Dabrowska E; Jabłońska-Kaszewska I; Lukasiak J; Dorosz A; Falkiewicz B
    Biofactors; 2000; 11(1-2):131-4. PubMed ID: 10705984
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyria cutanea tarda.
    Bleasel NR; Varigos GA
    Australas J Dermatol; 2000 Nov; 41(4):197-206; quiz 207-8. PubMed ID: 11105361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.